Dentium (145720) - Net Assets
Based on the latest financial reports, Dentium (145720) has net assets worth ₩561.21 Billion KRW (≈ $380.32 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩932.79 Billion ≈ $632.14 Million USD) and total liabilities (₩371.58 Billion ≈ $251.82 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 145720 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩561.21 Billion |
| % of Total Assets | 60.16% |
| Annual Growth Rate | 27.67% |
| 5-Year Change | 92.79% |
| 10-Year Change | 708.19% |
| Growth Volatility | 36.01 |
Dentium - Net Assets Trend (2015–2025)
This chart illustrates how Dentium's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Dentium (145720) total market value.
Annual Net Assets for Dentium (2015–2025)
The table below shows the annual net assets of Dentium from 2015 to 2025. Also explore 145720 net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩561.21 Billion ≈ $380.32 Million |
+1.39% |
| 2024-12-31 | ₩553.51 Billion ≈ $375.10 Million |
+19.32% |
| 2023-12-31 | ₩463.87 Billion ≈ $314.36 Million |
+24.31% |
| 2022-12-31 | ₩373.16 Billion ≈ $252.89 Million |
+28.19% |
| 2021-12-31 | ₩291.10 Billion ≈ $197.27 Million |
+27.34% |
| 2020-12-31 | ₩228.60 Billion ≈ $154.92 Million |
+10.68% |
| 2019-12-31 | ₩206.53 Billion ≈ $139.96 Million |
+6.06% |
| 2018-12-31 | ₩194.73 Billion ≈ $131.97 Million |
+19.86% |
| 2017-12-31 | ₩162.46 Billion ≈ $110.10 Million |
+133.96% |
| 2016-12-31 | ₩69.44 Billion ≈ $47.06 Million |
+42.40% |
| 2015-12-31 | ₩48.76 Billion ≈ $33.05 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dentium's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 561.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩507.39 Billion | 90.21% |
| Other Components | ₩55.04 Billion | 9.79% |
| Total Equity | ₩562.43 Billion | 100.00% |
Dentium Competitors by Market Cap
The table below lists competitors of Dentium ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Profound Medical Corp
TO:PRN
|
$218.07 Million |
|
Vestland Berhad
KLSE:0273
|
$218.12 Million |
|
Tunas Baru Lampung Tbk
JK:TBLA
|
$218.13 Million |
|
Polytronics Technology Corp
TW:6224
|
$218.14 Million |
|
Eastern Water Resources Development and Management Public Company Limited
F:7ES1
|
$217.95 Million |
|
Kardan Israel Ltd
TA:KRDI
|
$217.91 Million |
|
TuanChe ADR
NASDAQ:TC
|
$217.88 Million |
|
Teamlease Services Limited
NSE:TEAMLEASE
|
$217.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dentium's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 554,666,082,970 to 562,431,790,930, a change of 7,765,707,960 (1.4%).
- Net income of 16,410,778,670 contributed positively to equity growth.
- Dividend payments of 5,174,334,600 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩16.41 Billion | +2.92% |
| Dividends Paid | ₩5.17 Billion | -0.92% |
| Other Changes | ₩-3.47 Billion | -0.62% |
| Total Change | ₩- | 1.40% |
Book Value vs Market Value Analysis
This analysis compares Dentium's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.57x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.99x to 0.57x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩18767.90 | ₩37300.00 | x |
| 2018-12-31 | ₩22506.11 | ₩37300.00 | x |
| 2019-12-31 | ₩23995.56 | ₩37300.00 | x |
| 2020-12-31 | ₩26588.26 | ₩37300.00 | x |
| 2021-12-31 | ₩33840.87 | ₩37300.00 | x |
| 2022-12-31 | ₩43354.09 | ₩37300.00 | x |
| 2023-12-31 | ₩53873.92 | ₩37300.00 | x |
| 2024-12-31 | ₩64317.38 | ₩37300.00 | x |
| 2025-12-31 | ₩65217.87 | ₩37300.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dentium utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.92%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.74%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 1.66x
- Recent ROE (2.92%) is below the historical average (17.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 29.84% | 15.17% | 0.63x | 3.10x | ₩9.63 Billion |
| 2016 | 28.68% | 16.49% | 0.64x | 2.72x | ₩12.89 Billion |
| 2017 | 18.58% | 19.96% | 0.48x | 1.92x | ₩13.88 Billion |
| 2018 | 17.65% | 18.38% | 0.43x | 2.25x | ₩14.84 Billion |
| 2019 | 7.15% | 5.85% | 0.46x | 2.64x | ₩-5.91 Billion |
| 2020 | 9.83% | 9.81% | 0.45x | 2.23x | ₩-384.71 Million |
| 2021 | 19.01% | 19.03% | 0.51x | 1.95x | ₩26.30 Billion |
| 2022 | 23.02% | 24.18% | 0.53x | 1.80x | ₩48.68 Billion |
| 2023 | 20.78% | 24.55% | 0.51x | 1.67x | ₩50.06 Billion |
| 2024 | 13.11% | 17.83% | 0.46x | 1.61x | ₩17.24 Billion |
| 2025 | 2.92% | 4.74% | 0.37x | 1.66x | ₩-39.83 Billion |
Industry Comparison
This section compares Dentium's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $76,342,789,196
- Average return on equity (ROE) among peers: 2.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dentium (145720) | ₩561.21 Billion | 29.84% | 0.66x | $217.99 Million |
| DIO Corporation (039840) | $142.42 Billion | 15.26% | 0.92x | $87.83 Million |
| Cellumed Co. Ltd (049180) | $23.02 Billion | -40.27% | 1.15x | $37.57 Million |
| Interojo Inc (119610) | $157.03 Billion | 8.24% | 0.56x | $105.82 Million |
| M.I.TECH Co.Ltd (179290) | $16.63 Billion | 12.09% | 0.23x | $99.25 Million |
| Kyobo 8 Special Purpose Acquisition Company (307280) | $42.62 Billion | 15.52% | 0.12x | $27.73 Million |
About Dentium
Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly … Read more